^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GEUS-CRC

    Company:
    Aniling
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    GEUS-CRC test facilitate the diagnosis, prognosis and selection of the best treatment for each patient with chronic lymphocytic leukaemia and colon cancer. GEUS-CRC and GEUS-LB tests are based on the patented GEUS (Genomic and Epigenomic Unified Sequencing) technology which, for the first time, simultaneously and highly reliably analyses genetic and epigenetic biomarkers in a single clinical test.
    Cancer:
    Colorectal Cancer
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    07/28/22
    CRC
    -
    CE